{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T06:47:11Z","timestamp":1793170031613,"version":"4.5.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07824-9","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T11:05:28Z","timestamp":1770980728000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["5-mC RNA methylation: a key regulator in cancer development and treatment"],"prefix":"10.1186","volume":"24","author":[{"given":"Ziyi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiqi","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4942-3648","authenticated-orcid":false,"given":"Kexi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"7824_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2991\/jegh.k.191008.001","volume":"9","author":"C Mattiuzzi","year":"2019","unstructured":"Mattiuzzi C, Lippi G. Current cancer epidemiology. J Epidemiol Glob Health. 2019;9(4):217\u201322.","journal-title":"J Epidemiol Glob Health"},{"key":"7824_CR2","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN. Jemal A: cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"7824_CR3","doi-asserted-by":"crossref","unstructured":"Feinberg AP, Levchenko A. Epigenetics as a mediator of plasticity in cancer. Science. 2023;379:eaaw 3835.","DOI":"10.1126\/science.aaw3835"},{"key":"7824_CR4","doi-asserted-by":"publisher","first-page":"1207371","DOI":"10.3389\/fimmu.2023.1207371","volume":"14","author":"X Gu","year":"2023","unstructured":"Gu X, Ma X, Chen C, Guan J, Wang J, Wu S, et al. Vital roles of m(5)C RNA modification in cancer and immune cell biology. Front Immunol. 2023;14:1207371.","journal-title":"Front Immunol"},{"key":"7824_CR5","doi-asserted-by":"publisher","first-page":"3369","DOI":"10.7150\/ijbs.61439","volume":"17","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Liu F, Chen W, Miao H, Liang H, Liao Z, et al. The role of RNA m(5)C modification in cancer metastasis. Int J Biol Sci. 2021;17(13):3369\u201380.","journal-title":"Int J Biol Sci"},{"key":"7824_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s40364-022-00362-8","volume":"10","author":"H Song","year":"2022","unstructured":"Song H, Zhang J, Liu B, Xu J, Cai B, Yang H, et al. Biological roles of RNA m(5)C modification and its implications in cancer immunotherapy. Biomark Res. 2022;10(1):15.","journal-title":"Biomark Res"},{"key":"7824_CR7","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1242\/jcs.181040","volume":"129","author":"J Hong","year":"2016","unstructured":"Hong J, Lee JH, Chung IK. Telomerase activates transcription of cyclin D1 gene through an interaction with NOL1. J Cell Sci. 2016;129(8):1566\u201379.","journal-title":"J Cell Sci"},{"key":"7824_CR8","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12915-020-00769-5","volume":"18","author":"U Schumann","year":"2020","unstructured":"Schumann U, Zhang HN, Sibbritt T, Pan A, Horvath A, Gross S, et al. Multiple links between 5-methylcytosine content of mRNA and translation. BMC Biol. 2020;18(1):40.","journal-title":"BMC Biol"},{"key":"7824_CR9","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41556-019-0361-y","volume":"21","author":"X Chen","year":"2019","unstructured":"Chen X, Li A, Sun BF, Yang Y, Han YN, Yuan X, et al. 5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs. Nat Cell Biol. 2019;21(8):978\u201390.","journal-title":"Nat Cell Biol"},{"key":"7824_CR10","doi-asserted-by":"crossref","unstructured":"Zou S, Huang Y, Yang Z, Zhang J, Meng M, Zhang Y, et al. NSUN2 promotes colorectal cancer progression by enhancing SKIL mRNA stabilization. Clin Transl Med. 2024;14(3):e1621.","DOI":"10.1002\/ctm2.1621"},{"key":"7824_CR11","doi-asserted-by":"publisher","first-page":"148162","DOI":"10.1016\/j.gene.2024.148162","volume":"901","author":"C Hou","year":"2024","unstructured":"Hou C, Liu J, Liu J, Yao D, Liang F, Qin C, et al. 5-methylcytosine-mediated upregulation of circular RNA 0102913 augments malignant properties of colorectal cancer cells through a microRNA-571\/Rac family small GTPase 2 axis. Gene. 2024;901:148162.","journal-title":"Gene"},{"key":"7824_CR12","doi-asserted-by":"publisher","first-page":"2805","DOI":"10.1002\/ijc.30691","volume":"140","author":"Z Yang","year":"2017","unstructured":"Yang X, Yang Y, Sun BF, et al. 5-methylcytosine promotes mRNA export - NSUN2 as the methyltransferase and ALYREF as an m5C reader. Cell Res. 2017;27(5):606\u2013625.","journal-title":"Int J Cancer"},{"key":"7824_CR13","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12943-023-01814-x","volume":"22","author":"Q Yang","year":"2023","unstructured":"Yang Q, Wang M, Xu J, Yu D, Li Y, Chen Y, et al. LINC02159 promotes non-small cell lung cancer progression via ALYREF\/YAP1 signaling. Mol Cancer. 2023;22(1):122.","journal-title":"Mol Cancer"},{"key":"7824_CR14","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/s41418-021-00920-x","volume":"29","author":"D Jiang","year":"2022","unstructured":"Jiang D, Qiu T, Peng J, Li S, Tala R, Yang W, et al. YB-1 is a positive regulator of KLF5 transcription factor in basal-like breast cancer. Cell Death Differ. 2022;29(6):1283\u201395.","journal-title":"Cell Death Differ"},{"key":"7824_CR15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bbrc.2019.09.098","volume":"520","author":"S Xue","year":"2019","unstructured":"Xue S, Xu H, Sun Z, Shen H, Chen S, Ouyang J, et al. Depletion of TRDMT1 affects 5-methylcytosine modification of mRNA and inhibits HEK293 cell proliferation and migration. Biochem Biophys Res Commun. 2019;520(1):60\u201366.","journal-title":"Biochem Biophys Res Commun"},{"key":"7824_CR16","doi-asserted-by":"publisher","first-page":"691","DOI":"10.7150\/ijbs.79205","volume":"19","author":"Y Chen","year":"2023","unstructured":"Chen Y, Zuo X, Wei Q, Xu J, Liu X, Liu S, et al. Upregulation of LRRC8A by m(5)C modification-mediated mRNA stability suppresses apoptosis and facilitates tumorigenesis in cervical cancer. Int J Biol Sci. 2023;19(2):691\u2013704.","journal-title":"Int J Biol Sci"},{"key":"7824_CR17","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.cub.2006.04.027","volume":"16","author":"M Frye","year":"2006","unstructured":"Frye M, Watt FM. The RNA methyltransferase Misu (NSun2) mediates myc-induced proliferation and is upregulated in tumors. Curr Biol. 2006;16(10):971\u201381.","journal-title":"Curr Biol"},{"key":"7824_CR18","doi-asserted-by":"publisher","first-page":"6906","DOI":"10.1038\/s41388-020-01475-w","volume":"39","author":"Z Sun","year":"2020","unstructured":"Sun Z, Xue S, Zhang M, Xu H, Hu X, Chen S, et al. Aberrant NSUN2-mediated m(5)C modification of H19 lncRNA is associated with poor differentiation of hepatocellular carcinoma. Oncogene. 2020;39(45):6906\u201319.","journal-title":"Oncogene"},{"key":"7824_CR19","first-page":"3858","volume":"12","author":"Z Jiang","year":"2020","unstructured":"Jiang Z, Li S, Han MJ, Hu GM, Cheng P. High expression of NSUN5 promotes cell proliferation via cell cycle regulation in colorectal cancer. Am J Transl Res. 2020;12(7):3858\u201370.","journal-title":"Am J Transl Res"},{"key":"7824_CR20","doi-asserted-by":"publisher","first-page":"331","DOI":"10.7150\/ijbs.82316","volume":"20","author":"J Nulali","year":"2024","unstructured":"Nulali J, Zhang K, Long M, Wan Y, Liu Y, Zhang Q, et al. ALYREF-mediated RNA 5-methylcytosine modification promotes hepatocellular carcinoma progression via stabilizing EGFR mRNA and pSTAT3 activation. Int J Biol Sci. 2024;20(1):331\u201346.","journal-title":"Int J Biol Sci"},{"key":"7824_CR21","doi-asserted-by":"publisher","first-page":"2263921","DOI":"10.1080\/15384047.2023.2263921","volume":"24","author":"S Yang","year":"2023","unstructured":"Yang S, Zhou D, Zhang C, Xiang J, Xi X. Function of m(5)C RNA methyltransferase NOP2 in high-grade serous ovarian cancer. Cancer Biol Ther. 2023;24(1):2263921.","journal-title":"Cancer Biol Ther"},{"key":"7824_CR22","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/s41419-023-05781-5","volume":"14","author":"Y Li","year":"2023","unstructured":"Li Y, Xia Y, Jiang T, Chen Z, Shen Y, Lin J, et al. Long noncoding RNA DIAPH2-AS1 promotes neural invasion of gastric cancer via stabilizing NSUN2 to enhance the m5C modification of NTN1. Cell Death Dis. 2023;14(4):260.","journal-title":"Cell Death Dis"},{"key":"7824_CR23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/s41420-023-01521-y","volume":"9","author":"G Zhang","year":"2023","unstructured":"Zhang G, Liu L, Li J, Chen Y, Wang Y, Zhang Y, et al. NSUN2 stimulates tumor progression via enhancing TIAM2 mRNA stability in pancreatic cancer. Cell Death Discov. 2023;9(1):219.","journal-title":"Cell Death Discov"},{"key":"7824_CR24","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nature12750","volume":"502","author":"RM Kohli","year":"2013","unstructured":"Kohli RM, Zhang Y. TET enzymes, TDG and the dynamics of DNA demethylation. Nature. 2013;502(7472):472\u201379.","journal-title":"Nature"},{"key":"7824_CR25","doi-asserted-by":"crossref","unstructured":"Putiri EL, Tiedemann RL, Thompson JJ, Liu C, Ho T, Choi JH, et al. Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human cancer cells. Genome Biol. 2014;15(6):R81.","DOI":"10.1186\/gb-2014-15-6-r81"},{"key":"7824_CR26","doi-asserted-by":"publisher","first-page":"31322","DOI":"10.18632\/oncotarget.8900","volume":"7","author":"YF Pei","year":"2016","unstructured":"Pei YF, Tao R, Li JF, Su LP, Yu BQ, Wu XY, et al. TET1 inhibits gastric cancer growth and metastasis by PTEN demethylation and re-expression. Oncotarget. 2016;7(21):31322\u201335.","journal-title":"Oncotarget"},{"key":"7824_CR27","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1186\/s13046-019-1334-5","volume":"38","author":"J Wu","year":"2019","unstructured":"Wu J, Li H, Shi M, Zhu Y, Ma Y, Zhong Y, et al. TET1-mediated DNA hydroxymethylation activates inhibitors of the Wnt\/\u03b2-catenin signaling pathway to suppress EMT in pancreatic tumor cells. J Exp Clin Cancer Res. 2019;38(1):348.","journal-title":"J Exp Clin Cancer Res"},{"key":"7824_CR28","doi-asserted-by":"crossref","unstructured":"Chen Q, Yin D, Zhang Y, Yu L, Li XD, Zhou ZJ, et al. MicroRNA-29a induces loss of 5-hydroxymethylcytosine and promotes metastasis of hepatocellular carcinoma through a TET-SOCS1-MMP9 signaling axis. Cell Death Dis. 2017;8(6):e2906.","DOI":"10.1038\/cddis.2017.142"},{"key":"7824_CR29","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1186\/s12885-023-11343-x","volume":"23","author":"G Cheng","year":"2023","unstructured":"Cheng G, Wu J, Ji M, Hu W, Wu C, Jiang J. TET2 inhibits the proliferation and metastasis of lung adenocarcinoma cells via activation of the cGAS-STING signalling pathway. BMC Cancer. 2023;23(1):825.","journal-title":"BMC Cancer"},{"key":"7824_CR30","doi-asserted-by":"crossref","unstructured":"Natarajan SK, Pun M, Haggerty-Skeans J, Venneti S. Integration and intersection of cancer metabolism with epigenetic pathways in gliomas. Annu Rev Pathol. 2025. 21(1):447-77","DOI":"10.1146\/annurev-pathmechdis-111523-023424"},{"key":"7824_CR31","doi-asserted-by":"crossref","unstructured":"Chen B, Deng Y, Hong Y, Fan L, Zhai X, Hu H, et al. Metabolic recoding of NSUN2-mediated m(5)C modification promotes the progression of colorectal cancer via the NSUN2\/YBX1\/m(5)C-ENO1 positive feedback Loop. Adv Sci (Weinh). 2024;11(28):e2309840.","DOI":"10.1002\/advs.202309840"},{"key":"7824_CR32","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2147\/OTT.S286408","volume":"14","author":"J Wang","year":"2021","unstructured":"Wang JZ, Zhu W, Han J, et al. The role of the HIF-1\u03b1\/ALYREF\/PKM2 axis in glycolysis and tumorigenesis of bladder cancer. Cancer Commun (Lond). 2021;41(7):560\u2013575.","journal-title":"Onco Targets Ther"},{"key":"7824_CR33","doi-asserted-by":"crossref","unstructured":"Pan W, Liu X, Liu S. ALYREF m5C RNA methylation reader predicts bladder cancer prognosis by regulating the tumor immune microenvironment. Med (Baltim). 2024;103(14):e37590.","DOI":"10.1097\/MD.0000000000037590"},{"key":"7824_CR34","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1038\/s41388-023-02707-5","volume":"42","author":"K Liu","year":"2023","unstructured":"Liu K, Xu P, Lv J, Ge H, Yan Z, Huang S, et al. Peritoneal high-fat environment promotes peritoneal metastasis of gastric cancer cells through activation of NSUN2-mediated ORAI2 m5C modification. Oncogene. 2023;42(24):1980\u201393.","journal-title":"Oncogene"},{"key":"7824_CR35","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/s12276-024-01184-4","volume":"56","author":"X Liu","year":"2024","unstructured":"Liu X, Wei Q, Yang C, Zhao H, Xu J, Mobet Y, et al. RNA m(5)C modification upregulates E2F1 expression in a manner dependent on YBX1 phase separation and promotes tumor progression in ovarian cancer. Exp Mol Med. 2024;56(3):600\u201315.","journal-title":"Exp Mol Med"},{"key":"7824_CR36","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1038\/s41418-023-01223-z","volume":"30","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen XN, Zhang H, Wen JK, Gao HT, Shi B, et al. CDK13 promotes lipid deposition and prostate cancer progression by stimulating NSUN5-mediated m5C modification of ACC1 mRNA. Cell Death Differ. 2023;30(12):2462\u201376.","journal-title":"Cell Death Differ"},{"key":"7824_CR37","doi-asserted-by":"publisher","first-page":"788801","DOI":"10.3389\/fonc.2022.788801","volume":"12","author":"X Tong","year":"2022","unstructured":"Tong X, Xiang Y, Hu Y, Hu Y, Li H, Wang H, et al. NSUN2 promotes tumor progression and regulates immune infiltration in nasopharyngeal carcinoma. Front Oncol. 2022;12:788801.","journal-title":"Front Oncol"},{"key":"7824_CR38","doi-asserted-by":"crossref","unstructured":"Cui Y, Lv P, Zhang C. NSUN6 mediates 5-methylcytosine modification of METTL3 and promotes colon adenocarcinoma progression. J Biochem Mol Toxicol. 2024;38(6):e23749.","DOI":"10.1002\/jbt.23749"},{"key":"7824_CR39","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/j.cmet.2023.07.009","volume":"35","author":"T Chen","year":"2023","unstructured":"Chen T, Xu ZG, Luo J, Manne RK, Wang Z, Hsu CC, et al. NSUN2 is a glucose sensor suppressing cGAS\/STING to maintain tumorigenesis and immunotherapy resistance. Cell Metab. 2023;35(10):1782\u201398.","journal-title":"Cell Metab"},{"key":"7824_CR40","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.7150\/jca.17689","volume":"8","author":"PK Maurya","year":"2017","unstructured":"Maurya PK, Mishra A, Yadav BS, Singh S, Kumar P, Chaudhary A, et al. Role of Y box protein-1 in cancer: As potential biomarker and novel therapeutic target. J Cancer. 2017;8(10):1900\u201307.","journal-title":"J Cancer"},{"key":"7824_CR41","doi-asserted-by":"publisher","first-page":"310","DOI":"10.3389\/fimmu.2020.00310","volume":"11","author":"M Abd Hamid","year":"2020","unstructured":"Abd Hamid M, Yao X, Waugh C, Rosendo-Machado S, Li C, Rostron T, et al. Defective Interferon Gamma production by tumor-specific CD8(+) T cells is associated with 5\u2018Methylcytosine-guanine hypermethylation of Interferon Gamma promoter. Front Immunol. 2020;11:310.","journal-title":"Front Immunol"},{"key":"7824_CR42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41420-024-01862-2","volume":"10","author":"Q Meng","year":"2024","unstructured":"Meng Q, Xie Y, Sun K, He L, Wu H, Zhang Q, et al. ALYREF-JunD-SLC7A5 axis promotes pancreatic ductal adenocarcinoma progression through epitranscriptome-metabolism reprogramming and immune evasion. Cell Death Discov. 2024;10(1):97.","journal-title":"Cell Death Discov"},{"key":"7824_CR43","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.trecan.2019.10.007","volume":"5","author":"K Mehla","year":"2019","unstructured":"Mehla K, Singh PK. Metabolic regulation of macrophage polarization in cancer. Trends Cancer. 2019;5(12):822\u201334.","journal-title":"Trends Cancer"},{"key":"7824_CR44","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/odi.14357","volume":"30","author":"S Jin","year":"2024","unstructured":"Jin S, Li J, Shen Y, Wu Y, Zhang Z, Ma H. RNA 5-methylcytosine regulator NSUN3 promotes tumor progression through regulating immune infiltration in head and neck squamous cell carcinoma. Oral Dis. 2024;30(2):313\u201328.","journal-title":"Oral Dis"},{"key":"7824_CR45","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1161\/CIRCRESAHA.115.307674","volume":"118","author":"Y Luo","year":"2016","unstructured":"Luo Y, Feng J, Xu Q, Wang W, Wang X. NSun2 deficiency protects endothelium from inflammation via mRNA methylation of ICAM-1. Circ Res. 2016;118(6):944\u201356.","journal-title":"Circ Res"},{"key":"7824_CR46","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41419-023-05661-y","volume":"14","author":"N Wang","year":"2023","unstructured":"Wang N, Tang H, Wang X, Wang W, Feng J. Homocysteine upregulates interleukin-17A expression via NSun2-mediated RNA methylation in T lymphocytes. Biochem Biophys Res Commun. 2017;493(1):94-99.","journal-title":"Cell Death Dis"},{"key":"7824_CR47","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41419-023-06241-w","volume":"14","author":"B Chen","year":"2023","unstructured":"Chen B, Hong Y, Zhai X, Deng Y, Hu H, Tian S, et al. m6A and m5C modification of GPX4 facilitates anticancer immunity via STING activation. Cell Death Dis. 2023;14(12):809.","journal-title":"Cell Death Dis"},{"key":"7824_CR48","doi-asserted-by":"crossref","unstructured":"Wu R, Sun C, Chen X, Yang R, Luan Y, Zhao X, et al. NSUN5\/TET2-directed chromatin-associated RNA modification of 5-methylcytosine to 5-hydroxymethylcytosine governs glioma immune evasion. Proc Natl Acad Sci U S A. 2024;121(14):e2321611121.","DOI":"10.1073\/pnas.2321611121"},{"key":"7824_CR49","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1038\/s41467-019-09541-y","volume":"10","author":"X Yue","year":"2019","unstructured":"Yue X, Lio CJ, Samaniego-Castruita D, Li X, Rao A. Loss of TET2 and TET3 in regulatory T cells unleashes effector function. Nat Commun. 2019;10(1):2011.","journal-title":"Nat Commun"},{"key":"7824_CR50","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","volume":"575","author":"N Vasan","year":"2019","unstructured":"Vasan N, Baselga J, Hyman DM. A view on drug resistance in cancer. Nature. 2019;575(7782):299\u2013309.","journal-title":"Nature"},{"key":"7824_CR51","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/s41467-018-03513-4","volume":"9","author":"JX Cheng","year":"2018","unstructured":"Cheng JX, Chen L, Li Y, Cloe A, Yue M, Wei J, et al. RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia. Nat Commun. 2018;9(1):1163.","journal-title":"Nat Commun"},{"key":"7824_CR52","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/15592294.2017.1414128","volume":"13","author":"T Morales-Ruiz","year":"2018","unstructured":"Wang Y, Wei J, Feng L, et al. Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2\/YBX1\/QSOX1 axis in EGFR-mutant non-small-cell lung cancer. Mol Cancer. 2023;22(1):81.","journal-title":"Epigenetics"},{"key":"7824_CR53","doi-asserted-by":"publisher","first-page":"106793","DOI":"10.1016\/j.jbc.2024.106793","volume":"300","author":"Y Chen","year":"2024","unstructured":"Chen Y, Jiang Z, Zhang C, Zhang L, Chen H, Xiao N, et al. 5-methylcytosine transferase NSUN2 drives NRF2-mediated ferroptosis resistance in non-small cell lung cancer. J Biol Chem. 2024;300:106793.","journal-title":"J Biol Chem"},{"key":"7824_CR54","doi-asserted-by":"publisher","first-page":"102975","DOI":"10.1016\/j.redox.2023.102975","volume":"69","author":"SJ Chen","year":"2024","unstructured":"Chen S, Zhang J, Zhou T, Rao S, Li Q, Xiao L, et al. Epigenetically upregulated NSUN2 confers ferroptosis resistance in endometrial cancer via m(5)C modification of SLC7A11 mRNA. Redox Biol. 2024;69:102975.","journal-title":"Redox Biol"},{"key":"7824_CR55","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.canlet.2018.05.013","volume":"430","author":"Y Li","year":"2018","unstructured":"Li Y, Li J, Luo M, Zhou C, Shi X, Yang W, et al. Novel long noncoding RNA NMR promotes tumor progression via NSUN2 and BPTF in esophageal squamous cell carcinoma. Cancer Lett. 2018;430:57\u201366.","journal-title":"Cancer Lett"},{"key":"7824_CR56","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1080\/15384047.2021.1990631","volume":"22","author":"CU Awah","year":"2021","unstructured":"Awah CU, Winter J, Mazdoom CM, Ogunwobi OO. NSUN6, an RNA methyltransferase of 5-mC controls glioblastoma response to temozolomide (TMZ) via NELFB and RPS6KB2 interaction. Cancer Biol Ther. 2021;22:587\u201397.","journal-title":"Cancer Biol Ther"},{"key":"7824_CR57","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1021\/acs.chemrestox.9b00012","volume":"32","author":"S Zhong","year":"2019","unstructured":"Zhong S, Li C, Han X, Li X, Yang YG, Wang H. Idarubicin stimulates cell cycle- and TET2-dependent oxidation of DNA 5-methylcytosine in cancer cells. Chem Res Toxicol. 2019;32:861\u201368.","journal-title":"Chem Res Toxicol"},{"key":"7824_CR58","doi-asserted-by":"publisher","first-page":"2190618","DOI":"10.1080\/07853890.2023.2190618","volume":"55","author":"Y Wang","year":"2023","unstructured":"Morales-Ruiz T, Garc\u00eda-Ortiz MV, Devesa-Guerra I, Raya-Ruiz L, Tejedor JR, Bay\u00f3n GF, et al. DNA methylation reprogramming of human cancer cells by expression of a plant 5-methylcytosine DNA glycosylase. Epigenetics. 2018;13:95\u2013107.","journal-title":"Ann Med"},{"key":"7824_CR59","doi-asserted-by":"publisher","first-page":"15833","DOI":"10.18632\/aging.203203","volume":"13","author":"D Bloniarz","year":"2021","unstructured":"Bloniarz D, Adamczyk-Grochala J, Lewinska A, Wnuk M. The lack of functional DNMT2\/TRDMT1 gene modulates cancer cell responses during drug-induced senescence. Aging (Albany NY). 2021;13:15833\u201374.","journal-title":"Aging (Albany NY)"},{"key":"7824_CR60","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s10495-022-01779-0","volume":"28","author":"J Adamczyk-Grochala","year":"2023","unstructured":"Adamczyk-Grochala J, Bloniarz D, Zielinska K, Lewinska A, Wnuk M. DNMT2\/TRDMT1 gene knockout compromises doxorubicin-induced unfolded protein response and sensitizes cancer cells to ER stress-induced apoptosis. Apoptosis. 2023;28:166\u201385.","journal-title":"Apoptosis"},{"key":"7824_CR61","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41389-022-00387-6","volume":"11","author":"W Gao","year":"2022","unstructured":"Gao W, Chen L, Lin L, Yang M, Li T, Wei H, et al. SIAH1 reverses chemoresistance in epithelial ovarian cancer via ubiquitination of YBX-1. Oncogenesis. 2022;11:13.","journal-title":"Oncogenesis"},{"key":"7824_CR62","doi-asserted-by":"crossref","unstructured":"Ortiz-Barahona V, Soler M, Davalos V, Garcia-Prieto CA, Janin M, Setien F, et al. Epigenetic inactivation of the 5-methylcytosine rna methyltransferase nsun7 is associated with clinical outcome and therapeutic vulnerability in liver cancer. Mol Cancer. 2023;22(1):83.","DOI":"10.1186\/s12943-023-01785-z"},{"key":"7824_CR63","doi-asserted-by":"crossref","unstructured":"Ding W, Zeng T, Tao W, Ge W, Deng J, Lei H, et al. Effect of lenalidomide on the human gastric cancer cell line sgc7901\/vincristine notch signaling. J Cancer Res Ther. 2018;14(Supplement):S237\u201342.","DOI":"10.4103\/0973-1482.183181"},{"key":"7824_CR64","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s12672-023-00671-w","volume":"14","author":"X Tan","year":"2023","unstructured":"Tan X, Cai Z, Chen G, Cai C, Chen J, Liang Y, et al. Identification and verification of an ALYREF-involved 5-methylcytosine based signature for stratification of prostate cancer patients and prediction of clinical outcome and response to therapies. Discov Oncol. 2023;14:62.","journal-title":"Discov Oncol"},{"key":"7824_CR65","doi-asserted-by":"publisher","first-page":"503","DOI":"10.32604\/or.2024.045050","volume":"32","author":"X Ye","year":"2024","unstructured":"Ye X, Tuo Z, Chen K, Wu R, Wang J, Yu Q, et al. Pan-cancer analysis of RNA 5-methylcytosine reader (ALYREF). Oncol Res. 2024;32:503\u201315.","journal-title":"Oncol Res"},{"key":"7824_CR66","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1021\/acsmedchemlett.9b00679","volume":"11","author":"B Kucukkaraduman","year":"2020","unstructured":"Kucukkaraduman B, Turk C, Fallacara AL, Isbilen M, Senses KM, Ayyildiz ZO, et al. Predictive gene signature for pyrazolopyrimidine derivative c-src inhibitor 10a sensitivity in melanoma cells. ACS Med Chem Lett. 2020;11:928\u201332.","journal-title":"ACS Med Chem Lett"},{"key":"7824_CR67","doi-asserted-by":"crossref","unstructured":"Yan G XX, Ru N, Wang SW, Sui ZY, Xu HJ, Yao YS, et al. The deficiency of 5-methylcytosine (5mC) and its ramification in the occurrence and prognosis of colon cancer. Med (Baltim). 2023;102:e34860.","DOI":"10.1097\/MD.0000000000034860"},{"key":"7824_CR68","doi-asserted-by":"publisher","first-page":"4239","DOI":"10.1016\/j.molcel.2023.11.003","volume":"83","author":"HL Ma","year":"2023","unstructured":"Ma HL, Bizet M, Soares Da Costa C, Murisier F, de Bony EJ, Wang MK, et al. SRSF2 plays an unexpected role as reader of m(5)C on mRNA, linking epitranscriptomics to cancer. Mol Cell. 2023;83:4239\u201354.","journal-title":"Mol Cell"},{"key":"7824_CR69","doi-asserted-by":"publisher","first-page":"8127","DOI":"10.1158\/0008-5472.CAN-09-0458","volume":"69","author":"M Schaefer","year":"2009","unstructured":"Schaefer M, Hagemann S, Hanna K, Lyko F. Azacytidine inhibits RNA methylation at DNMT2 target sites in human cancer cell lines. Cancer Res. 2009;69:8127\u201332.","journal-title":"Cancer Res"},{"key":"7824_CR70","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.redox.2017.03.014","volume":"12","author":"A Lewinska","year":"2017","unstructured":"Lewinska A, Bednarz D, Adamczyk-Grochala J, Wnuk M. Phytochemical-induced nucleolar stress results in the inhibition of breast cancer cell proliferation. Redox Biol. 2017;12:469\u201382.","journal-title":"Redox Biol"},{"key":"7824_CR71","doi-asserted-by":"crossref","unstructured":"Xiang S, Ma Y, Shen J, Zhao Y, Wu X, Li M, et al. M(5)c rna methylation primarily affects the erbb and pi3k-akt signaling pathways in gastrointestinal cancer. Front Mol Biosci. 2020;7:599340.","DOI":"10.3389\/fmolb.2020.599340"},{"key":"7824_CR72","doi-asserted-by":"crossref","unstructured":"Segovia C, San Jose-Eneriz E, Munera-Maravilla E, Martinez-Fernandez M, Garate L, Miranda E, et al. Inhibition of a g9a\/dnmt network triggers immune-mediated bladder cancer regression. Nat Med. 2019;25(7):1073\u201381.","DOI":"10.1038\/s41591-019-0499-y"},{"key":"7824_CR73","doi-asserted-by":"publisher","first-page":"967921","DOI":"10.3389\/fimmu.2022.967921","volume":"13","author":"H Yin","year":"2022","unstructured":"Yin H, Huang Z, Niu S, Ming L, Jiang H, Gu L, et al. 5-methylcytosine (m(5)C) modification in peripheral blood immune cells is a novel non-invasive biomarker for colorectal cancer diagnosis. Front Immunol. 2022;13:967921.","journal-title":"Front Immunol"},{"key":"7824_CR74","doi-asserted-by":"publisher","first-page":"1099703","DOI":"10.3389\/fendo.2023.1099703","volume":"14","author":"F Tang","year":"2023","unstructured":"Tang F, Liu Y, Sun Y, Xiong Y, Gu Y, Zhou J, et al. Construction of a serum diagnostic signature based on m5C-related miRnas for cancer detection. Front Endocrinol (Lausanne). 2023;14:1099703.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7824_CR75","doi-asserted-by":"publisher","first-page":"1049435","DOI":"10.3389\/fimmu.2022.1049435","volume":"13","author":"B Chen","year":"2022","unstructured":"Chen B, Xi Y, Zhao J, Hong Y, Tian S, Zhai X, et al. m5C regulator-mediated modification patterns and tumor microenvironment infiltration characterization in colorectal cancer: one step closer to precision medicine. Front Immunol. 2022;13:1049435.","journal-title":"Front Immunol"},{"key":"7824_CR76","doi-asserted-by":"publisher","first-page":"9598","DOI":"10.1021\/acs.analchem.3c01252","volume":"95","author":"MH Gao","year":"2023","unstructured":"Gao MH, Pan MC, Zhang P, Liang WB, Zhong X, Zhuo Y. Identification and quantification of 5-methylcytosine and 5-hydroxymethylcytosine on random DNA sequences by a nanoconfined electrochemiluminescence platform. Anal Chem. 2023;95:9598\u2013604.","journal-title":"Anal Chem"},{"key":"7824_CR77","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1158\/2326-6066.CIR-18-0648","volume":"7","author":"Z Tao","year":"2019","unstructured":"Tao Z, Ruan H, Sun L, Kuang D, Song Y, Wang Q, et al. Targeting the YB-1\/PD-L1 axis to enhance chemotherapy and antitumor immunity. Cancer Immunol Res. 2019;7:1135\u201347.","journal-title":"Cancer Immunol Res"},{"key":"7824_CR78","doi-asserted-by":"publisher","first-page":"10695","DOI":"10.1093\/nar\/gkac817","volume":"50","author":"H Liao","year":"2022","unstructured":"Liao H, Gaur A, McConie H, Shekar A, Wang K, Chang JT, et al. Human NOP2\/NSUN1 regulates ribosome biogenesis through non-catalytic complex formation with box C\/D snoRnps. Nucleic Acids Res. 2022;50:10695\u2013716.","journal-title":"Nucleic Acids Res"},{"key":"7824_CR79","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/s41375-024-02250-6","volume":"38","author":"N Noronha","year":"2024","unstructured":"Noronha N, Durette C, Cahuzac M, Es B, Courtois J, Humeau J, et al. Autophagy degrades immunogenic endogenous retroelements induced by 5-azacytidine in acute myeloid leukemia. Leukemia. 2024;38:1019\u201331.","journal-title":"Leukemia"},{"key":"7824_CR80","doi-asserted-by":"crossref","unstructured":"Tyagi L, Kumar U, Mishra S, Simran R, Parashar G, D. Epigenetic analysis in cancer research. Methods Cell Biol. 2025;198:135\u201372.","DOI":"10.1016\/bs.mcb.2025.02.021"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07824-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07824-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07824-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T11:02:44Z","timestamp":1773140564000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07824-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7824"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07824-9","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"assertion":[{"value":"8 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have approved the final manuscript and the submission to this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"338"}}